Currently, active compounds (e.g. pharmaceutical and/or nutraceutical active ingredients) are administered intravenously, intramuscularly or orally. These conventional methods of administration have their own shortcomings. For example, intravenous administration often requires an expensive clinical setting, is invasive, painful and not suitable for individuals who have a phobia of needles. Oral administration (e.g. via the consumption of capsules, tablets, mixtures and suspensions) is also not a suitable method for the delivery of active compounds which are effectively lost during hepatic (first-pass liver metabolism) and/or gastrointestinal metabolism, a process that affects the bioavailability of numerous active compounds when ingested orally. Oral ingestion can also delay the onset of a therapeutic effect by several hours. The technology is a proprietary wafer formulation that allows pharmaceutical and/or nutraceutical active compounds to be administered sublingually, allowing for these compounds to be delivered safely, rapidly and conveniently into the blood stream. The technology is a superior mode of delivery as it reduces the effects of hepatic and gastrointestinal metabolism. Using the technology, sublingual delivery increases the rate and predictability of already approved drugs, resulting in an increase of new and improved clinical applications.

The core technology is a low code Blockchain Platform-as-a-Service (BPaaS) that enables quicker and more cost efficient blockchain application development and delivery at scale. The technology can be considered a tool that abstracts away the complexity of blockchain technology and enables any developer to easily build blockchain based applications or integrate blockchain functionality into their existing solutions and business operations.

The technology provides the method and system which allow end users to participate in the trading of resources, enabling the lowering of costs for the end users. Additionally, the method and system also allow for utilization of resources in a manner, which can optimize a load (for example, electrical) for the resource supply.   The technology includes the control of thermal load (e.g. aircon), management of energy storage (e.g. charge and discharge battery), mitigation of intermittency in renewable energy and setting of incentive and pricing based on users’ preference etc.   The technology is targeting the energy domain, in particular demand response management, energy saving scheme, renewable energy management, or energy storage optimization.

This Technology Offer is a medical-grade solution for patients who require continuous heart rhythm monitoring and diagnostics from any remote location. The solution bridges a significant gap between extended Holter diagnostics and remote telemetry. The data is transmitted ‘live’ by patients, and the review of data and reporting can be completed even before device is returned to the institution. This monitoring system can be deployed in scale across large geographical locations, as it uses cloud-based technologies to simplify collection of continuous ‘live-streamed’ electrocardiogram (ECG) from any connected location worldwide.

The Singapore-France Joint Innovation Call offers French and Singapore companies the opportunity to collaborate on joint innovation projects with each other. Proposals focusing on developing innovative products and applications in any technological area are welcome. Applicants are expected to develop ready-to-market solutions for products, technology-based services or methods which have strong potential for the French, Singaporean and/or international market. Enterprise Singapore and Bpifrance will provide access to public funding for jointly selected projects. The programme aims to encourage the development of ready-to-market solutions for products, technology-based services or methods that have strong potential for the French, Singapore or international market. More information about the submission process can be found at www.go.gov.sg/sg-france-joint-call.

Are you a German or Singapore technology company looking for partners to co-innovate on product development, access new markets and tap R&D funding? Enterprise Singapore and the German Federal Ministry for Economic Affairs and Energy (Coordinator: AiF Projekt GmbH) are announcing the 4th call for proposals for joint R&D and innovation projects between Singapore and Germany. Singapore and German-based SMEs are invited to submit joint projects in the research and development of innovative products and applications, with the end goal of commercialisation. The call for proposal is open to all technological and application areas.

A Singapore-based insect feed company is seeking automation and sensor technology for the insect farming process. The company has developed the know-how to farm insects including black soldier fly (BSF) and mealworms using organic food waste residues as nutritious feed for the insects. Young insect larvae will be grown from eggs until the ideal weight has been met in standardized crates and racking units. Afterwhich, the larvae will be separated from the rearing residue (substrate) for harvesting. In general, solutions and technologies that automate and optimise the insect farming process including feeding, weighing, harvesting and drying are of interest to the tech seeker.

A Singapore-based logistics company is seeking solution providers with expertise in retrofitting a fleet of manual pallet jacks for automated operations. The application scenario involves the regular transportation of sensitive equipment from vehicle loading bays to designated locations inside a manufacturing plant. Items to be transported are typically loaded onto several pallet jacks (5 or more) for transporting into a location for offloading and installation. The operation of these manual pallet jacks require one worker to be assigned to each pallet jack, and multiple trips are often involved.  A solution to reduce the manpower requirements for this task is thus desired, to enable one worker to handle several pallet jacks concurrently.